Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites
Journal of Clinical Investigation · 2023
DOI: 10.1172/jci170195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2023. Verfasst von Divya Bezwada und 1 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center Research Institute. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Children's Medical Center Research Institute.
- Kidney Cancer Program, Simmons Comprehensive Cancer Center, and.
- Department of Internal Medicine, Division of Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Förderung
- NIDDK NIH HHS
- NCI NIH HHS
Zitieren
APA
Bezwada, D., & Brugarolas, J. (2023). Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites. Journal of Clinical Investigation. https://doi.org/10.1172/jci170195
Vancouver
Bezwada D, Brugarolas J. Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites. Journal of Clinical Investigation. 2023. doi:10.1172/jci170195
BibTeX
@article{Bezwada2023,
author = {Bezwada, Divya and Brugarolas, James},
title = {Reporting on FH-deficient renal cell carcinoma using circulating succinylated metabolites},
journal = {Journal of Clinical Investigation},
year = {2023},
doi = {10.1172/jci170195}
}
EUVIMED